Page 8 - Biolase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biolase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biolase Today - Breaking & Trending Today

Short Interest in BIOLASE, Inc. (NASDAQ:BIOL) Expands By 219.5%

BIOLASE, Inc. (NASDAQ:BIOL – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 815,700 shares, a growth of 219.5% from the April 15th total of 255,300 shares. Based on an average daily volume of 1,030,000 shares, the short-interest […] ....

Renaissance Technologies , Essex Investment Management Co , Biolase Inc , Citadel Advisors , Perkins Capital Management Inc , Get Rating , Street Capital , Street Corp , Investment Management , Perkins Capital Management , Capital Management , Nasdaq Biol ,

BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31,. ....

John Beaver , Michael Polyviou Todd Kehrli , Biolase Inc , Company Waterlase Exclusive Trial Program , Waterlase Exclusive Trial Program , Source Biolase Inc , Exchange Commission , Training Programs Introducing Broader Community , Experience Industry Leading Dental Lasers , First Time , Waterlase Exclusive Trial , Chief Executive , Full Year Financial Guidance , Waterlase Express , Private Securities Litigation Reform Act , Operating Activities , Investing Activities , Financing Activities , Loss Per Share ,

StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

Equities researchers at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research report issued on Monday. The brokerage set a “sell” rating on the medical technology company’s stock. A number of other equities analysts also recently issued reports on BIOL. Lake Street Capital reaffirmed a “buy” rating on shares of […] ....

Citadel Advisors , Essex Investment Management Co , Perkins Capital Management Inc , Renaissance Technologies , Biolase Inc , Get Rating , Street Capital , Street Corp , Capital Management , Essex Investment Management , Investment Management , Nasdaq Biol , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the medical technology company’s stock. Several other research analysts have also recently issued reports on the company. Lake Street Capital restated a buy rating on shares of BIOLASE in a […] ....

Renaissance Technologies , Armistice Capital , Citadel Advisors , Biolase Inc , Essex Investment Management Co , Get Rating , Street Capital , Street Corp , Investment Management , Nasdaq Biol , Initiated Coverage , Stocknews Com ,

BIOLASE : Submission of Matters to a Vote of Security Holders - Form 8-K

8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to. | May 3, 2023 ....

United States , Lake Forest , Johnr Beaver , Jess Roper , Kenneth Yale , Carol Summerhays , Martha Somerman , Kathleent Oloughlin , Biolase Inc , Securities Exchange , Stock Market , Towne Centre , Commission File Number , Securities Exchange Act , Its Charter , Centre Drive , Principal Executive Offices , Zip Code , Telephone Number , Including Area Code , Former Name , Former Address , Changed Since Last Report , Securities Act , Exchange Act , Annual Meeting ,